and Metabolic Disease
暂无分享,去创建一个
[1] G. Garg,et al. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[2] E. Latz,et al. Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.
[3] R. Flavell,et al. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy , 2013, Kidney international.
[4] K. Schroder,et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC , 2013, Cell Death and Differentiation.
[5] Liang Zheng,et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.
[6] Fernanda S. Oliveira,et al. Critical Role of ASC Inflammasomes and Bacterial Type IV Secretion System in Caspase-1 Activation and Host Innate Resistance to Brucella abortus Infection , 2013, The Journal of Immunology.
[7] S. Akira,et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome , 2013, Nature Immunology.
[8] F. Sutterwala,et al. TRPM2 links oxidative stress to the NLRP3 inflammasome activation , 2013, Nature Communications.
[9] Kazuhide Yamamoto,et al. Role of gut microbiota in liver diseases , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.
[10] J. Tanti,et al. Implication of inflammatory signaling pathways in obesity-induced insulin resistance , 2013, Front. Endocrin..
[11] H. Anders,et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. , 2013, The Journal of clinical investigation.
[12] M. Heneka,et al. NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.
[13] E. Elinav,et al. The intestinal microbiota in chronic liver disease. , 2013, Advances in immunology.
[14] R. Weiskirchen,et al. Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease , 2012, Journal of Inflammation.
[15] S. Hida,et al. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. , 2012, Biochemical and biophysical research communications.
[16] C. Siu,et al. Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes , 2012, Cardiovascular Diabetology.
[17] Jos W. M. van der Meer,et al. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.
[18] Kenta Moriwaki,et al. The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis , 2012, Cell.
[19] S. Subramanian,et al. Toll-Like Receptor 4 Deficiency Decreases Atherosclerosis But Does Not Protect Against Inflammation in Obese Low-Density Lipoprotein Receptor–Deficient Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[20] E. Podrez,et al. Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. , 2012, Cell metabolism.
[21] P. Cresswell,et al. GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals , 2012, Science.
[22] A. Bowie,et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. , 2012, Immunity.
[23] T. Kadowaki,et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. , 2012, Cell metabolism.
[24] Y. Rojanasakul,et al. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. , 2012, Immunity.
[25] E. Elinav,et al. Inflammasomes: far beyond inflammation , 2012, Nature Immunology.
[26] Haitao Wen,et al. A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation? , 2012, Nature Immunology.
[27] G. Shulman,et al. Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.
[28] J. Gage,et al. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. , 2012, The Canadian journal of cardiology.
[29] N. Nakasone,et al. Inflammasome activation via intracellular NLRs triggered by bacterial infection , 2012, Cellular microbiology.
[30] Richard A. Flavell,et al. Inflammasomes in health and disease , 2012, Nature.
[31] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[32] A. So,et al. Osteoarthritis: Crystal-gazing into the pathogenesis of osteoarthritis , 2011, Nature Reviews Rheumatology.
[33] Hyon K. Choi,et al. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.
[34] Hao Xu,et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.
[35] R. Flavell,et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy , 2011, Proceedings of the National Academy of Sciences.
[36] E. Latz,et al. NLRP3 inflammasomes link inflammation and metabolic disease. , 2011, Trends in immunology.
[37] R. Vance,et al. Innate immune recognition of bacterial ligands by NAIPs dictates inflammasome specificity , 2011, Nature.
[38] Anna K Rieger,et al. Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome , 2011, The Journal of Immunology.
[39] A. Dolganiuc,et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells , 2011, Hepatology.
[40] E. Elinav,et al. Regulation of the antimicrobial response by NLR proteins. , 2011, Immunity.
[41] Richard A. Flavell,et al. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.
[42] Michael J. Davis,et al. Sensing prokaryotic mRNA signifies microbial viability and promotes immunity , 2011, Nature.
[43] A. So,et al. Extended Report , 2022 .
[44] Denis Gris,et al. Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.
[45] Ping Zhang,et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity , 2011, Nature Medicine.
[46] S. Tangye,et al. Inflammatory Mechanisms in Obesity , 2013 .
[47] G. Hansson,et al. The immune system in atherosclerosis , 2011, Nature Immunology.
[48] J. Tschopp,et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome , 2011, Cell Death and Disease.
[49] T. Roger,et al. Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro , 2011, The Journal of Immunology.
[50] S. Shoelson,et al. Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.
[51] A. C. Könner,et al. Toll-like receptors: linking inflammation to metabolism , 2011, Trends in Endocrinology & Metabolism.
[52] Kim M. Huffman,et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation , 2011, Proceedings of the National Academy of Sciences.
[53] J. Tschopp,et al. A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.
[54] E. Ravussin,et al. The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.
[55] L. Joosten,et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. , 2010, Cell metabolism.
[56] K. Moore,et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.
[57] E. Podrez,et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands , 2010, Nature.
[58] A. So,et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study. , 2010, Arthritis and rheumatism.
[59] Christine E. Becker,et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.
[60] M. Donath,et al. Role of IL-1β in type 2 diabetes , 2010, Current opinion in endocrinology, diabetes, and obesity.
[61] D. Brenner,et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. , 2010, Gastroenterology.
[62] Eva Szomolanyi-Tsuda,et al. The AIM2 inflammasome is essential for host-defense against cytosolic bacteria and DNA viruses , 2010, Nature Immunology.
[63] A. Iwasaki,et al. Influenza virus activates inflammasomes through intracellular M2 channel , 2010, Nature Immunology.
[64] P. Ricciardi-Castagnoli,et al. The controversial relationship between NLRP3, alum, danger signals and the next‐generation adjuvants , 2010, European journal of immunology.
[65] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[66] E. Latz. The inflammasomes: mechanisms of activation and function. , 2010, Current opinion in immunology.
[67] J. Tschopp,et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.
[68] Kate Schroder,et al. The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.
[69] B. Dahlöf,et al. Cardiovascular disease risk factors: epidemiology and risk assessment. , 2010, The American journal of cardiology.
[70] F. Sutterwala,et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome , 2009, Proceedings of the National Academy of Sciences.
[71] I. Verma,et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.
[72] G. Lacraz,et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat , 2009, Proceedings of the National Academy of Sciences.
[73] R. Terkeltaub,et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study , 2009, Annals of the rheumatic diseases.
[74] E. Alnemri,et al. Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.
[75] G. Núñez,et al. Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1 , 2009, The Journal of Immunology.
[76] R. Medzhitov. Approaching the asymptote: 20 years later. , 2009, Immunity.
[77] R. Terkeltaub,et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis , 2009, Annals of the rheumatic diseases.
[78] J. Bastard,et al. The role of interleukins in insulin resistance and type 2 diabetes mellitus , 2009, Nature Reviews Endocrinology.
[79] G. La Torre,et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.
[80] F. Martinon,et al. The inflammasomes: guardians of the body. , 2009, Annual review of immunology.
[81] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[82] W. Martin,et al. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. , 2009, Arthritis and rheumatism.
[83] Marnie L. Gruen,et al. Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice , 2009, Diabetologia.
[84] M. Lemoine,et al. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. , 2008, Diabetes & metabolism.
[85] E. Zorrilla,et al. Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. , 2008, Swiss medical weekly.
[86] H. Hammad,et al. Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome , 2008, The Journal of Immunology.
[87] S. Amar,et al. Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings , 2008, PloS one.
[88] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[89] K. Moore,et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.
[90] F. Re,et al. Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31 , 2008, The Journal of Immunology.
[91] Richard A. Flavell,et al. The Nalp3 inflammasome is essential for the development of silicosis , 2008, Proceedings of the National Academy of Sciences.
[92] R. Medzhitov. Origin and physiological roles of inflammation , 2008, Nature.
[93] Richard A. Flavell,et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.
[94] V. Nizet,et al. A Nod2–nalp1 Complex Mediates Caspase-1-dependent Il-1 Secretion in Response to Bacillus Anthracis Infection and Muramyl Dipeptide Nod2, a Nod-like Receptor (nlr), Is an Intracellular Sensor of Bacterial Muramyl Dipeptide (mdp) That Was Suggested to Promote Secretion of the Proinflammatory Cytokine , 2022 .
[95] A. Surprenant,et al. P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage1 , 2008, The Journal of Immunology.
[96] J. Tschopp,et al. Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.
[97] L. Joosten,et al. Engagement of NOD2 has a dual effect on proIL‐1β mRNA transcription and secretion of bioactive IL‐1β , 2008, European journal of immunology.
[98] P. Adegboyega,et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. , 2007, Journal of hepatology.
[99] T. Hawn,et al. Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity , 2007, Circulation research.
[100] Z. Ye,et al. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling , 2007, Proceedings of the National Academy of Sciences.
[101] G. Salvesen,et al. The apoptosome: signalling platform of cell death , 2007, Nature Reviews Molecular Cell Biology.
[102] Allan Vaag,et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.
[103] J. Tschopp,et al. A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.
[104] Y. Le Marchand-Brustel,et al. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.
[105] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[106] R. Kitazawa,et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.
[107] Shizuo Akira,et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance , 2006, Nature Medicine.
[108] V. Dixit,et al. Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.
[109] F. Martinon,et al. Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.
[110] R. Leibel,et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.
[111] P. Tobias,et al. Modulation of atherosclerosis in mice by Toll-like receptor 2. , 2005, The Journal of clinical investigation.
[112] S. Akira,et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[113] M. Torrisi,et al. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[114] K. Moore,et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.
[115] R. North,et al. Rapid secretion of interleukin-1β by microvesicle shedding , 2001 .
[116] S. Seino,et al. S20G mutation of the amylin gene is associated with Type II diabetes in Japanese , 2001, Diabetologia.
[117] J. Clore,et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.
[118] B. Cookson,et al. Pro-inflammatory programmed cell death. , 2001, Trends in microbiology.
[119] T. Wallis,et al. Salmonella enterica Serovars Typhimurium and Dublin Can Lyse Macrophages by a Mechanism Distinct from Apoptosis , 2000, Infection and Immunity.
[120] Roger Davis,et al. The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.
[121] M. Visser,et al. Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.
[122] M. Torrisi,et al. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.
[123] M. A. Crook,et al. Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.
[124] S. Falkow,et al. Salmonella typhimurium invasion induces apoptosis in infected macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[125] M. Pettermann,et al. Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients. , 1996, The American journal of clinical nutrition.
[126] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[127] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[128] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[129] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[130] M. Prevost,et al. Shigella flexneri induces apoptosis in infected macrophages , 1992, Nature.